MedPath

ow dose chemoprofylaxis (LDCP) and reduction of pyelonephritic episodes and significant bacteriuria in children with meningomyelocele and clean intermittent catherisation (CIC).

Recruiting
Conditions
meningomyeloceleneuropathic bladder-sphincter dysfunctionspina bifidaurinary tract infections
Registration Number
NL-OMON23169
Lead Sponsor
Mrs. P. Winkler-Seinstra, research, UMCUdr. B Zegers, pediatrician, UMCUdr. P. Dik, pediatric urologist, UMCUdr. W. Feitz, pediatric urologist, UMCNdr. R. de Gier, pediatric urologist, UMC
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
170
Inclusion Criteria

1. Neuropathic bladder-sphincter dysfunction;

Exclusion Criteria

1. Urinary tract infection (UTI) or
- pyelonephritis at inclusion;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath